Stockscreener 앱 받기
1.59
2.58%
0.04
Regulus Therapeutics Inc (RGLS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
6.34%
8.826
|
8.30 | 8.125 | 7.315 | 7.369 |
| Interest Income/Expense |
28.95%
0.081
|
0.114 | 0.137 | 0.168 | 0.185 |
| Operating Income/Loss |
6.34%
-8.826
|
-8.30 | -8.125 | -7.315 | -7.369 |
| Income/Loss From Continuing Operations Before Tax |
5.06%
-8.469
|
-8.061 | -7.824 | -7.012 | -7.139 |
| Income/Loss From Continuing Operations After Tax |
5.06%
-8.469
|
-8.061 | -7.824 | -7.013 | -7.139 |
|
Net Income/Loss
|
5.06%
-8.469
|
-8.061 | -7.824 | -7.013 | -7.139 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6,661%
28.75
|
0.4252 | 19.63 | 19.10 | 16.84 |
| Diluted Average Shares |
6,661%
28.75
|
0.4252 | 19.63 | 19.10 | 16.84 |
| Basic Earnings Per Share |
110.47%
-0.29
|
2.77 | -0.40 | -0.37 | -0.42 |
| Diluted Earnings Per Share |
110.47%
-0.29
|
2.77 | -0.40 | -0.37 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
자본화:
|
볼륨(24시간):